Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Pancreatic Neoplasms 2Pain, Postoperative 2Neoplasms 2Melanoma 2Warts 1Surgical Wound 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasms, Fibrous Tissue 1Neoplasms, Connective and Soft Tissue 1Neoplasms, Connective Tissue 1Neoplasms by Histologic Type 1Myoma 1Musculoskeletal Diseases 1Meningioma 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Locally Advanced Cervical Cancer 1Leiomyoma 1Joint Diseases 1Hemorrhage 1Hematologic Neoplasms 1Fibroma 1Esophageal Neoplasms 1Dupuytren Contracture 1Contracture 1Connective Tissue Diseases 1Chronic Pain 1Brain Neoplasms 1

Interventions

Sodium Chloride 1Blood Specimen Collection 1Amiodarone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Atrial Fibrillation × Sodium Chloride × Clear all
NCT06067438 2026-05-22

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Atrial Fibrillation, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡